ALSF
Research Accelerating RUNX1 Exploration (RARE) Grant
Up to $250,0002 years
Last verified:
Details
| Funder | ALSF |
| Budget | Up to $250,000 |
| Duration | 2 years |
| Consortium | No |
Eligibility & scope
Funds research aimed at developing therapies for RUNX1-familial platelet disorder (RUNX1-FPD), specifically targeting interception of the transition from clonal hematopoiesis to MDS/AML or prevention of cancer before clonal hematopoiesis. Currently open for applications.
More from ALSF
ALSF 'A' Award Grant
Deadline: 15 May 2026Up to $100,000/yearALSF R Accelerator Grant 2026
Deadline: 4 Jun 2026VariesBio-Therapeutic Impact Grant
Deadline: 9 Jun 2026R Accelerator Grant
Deadline: 11 Jun 2026Alex's Lemonade Stand Foundation R Accelerated Grant 2026
Deadline: 11 Jun 2026Accelerated research funding for childhood cancer
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free